Website stats for Silicofcm - silicofcm.eu
The aim of SILICOFCM project (In Silico trials for drug tracing the effects of sarcomeric protein mutations leading to familial cardiomyopathy) is to develop a computational platform for in silico clinical trials of FCMs that would take into consideration comprehensive list of patient specific features (genetic, biological, pharmacologic, clinical, imaging and patient specific cellular aspects) ca...
It is a domain having .eu extension. It is estimated worth of $ 8.95 and have a daily income of around $ 0.15. As no active threats were reported recently, silicofcm.eu is SAFE to browse.
Traffic Report
| Daily Unique Visitors: | Not Applicable |
| Daily Pageviews: | Not Applicable |
Estimated Valuation
| Income Per Day: | $ 0.15 |
| Estimated Worth: | $ 8.95 |
Search Engine Indexes
| Google Indexed Pages: | Not Applicable |
| Yahoo Indexed Pages: | Not Applicable |
| Bing Indexed Pages: | 19 |
Search Engine Backlinks
| Google Backlinks: | Not Applicable |
| Bing Backlinks: | 73 |
| Alexa BackLinks: | Not Applicable |
Safety Information
| Google Safe Browsing: | No Risk Issues |
| Siteadvisor Rating: | Not Applicable |
| WOT Trustworthiness: |
 Very Poor
|
| WOT Privacy: |
Very Poor
|
| WOT Child Safety: |
Very Poor
|
Website Ranks & Scores
| Alexa Rank: | Not Applicable |
| PageSpeed Score: | 89 ON 100 |
| Domain Authority: |
49 ON 100 
|
| Bounce Rate: | Not Applicable |
| Time On Site: | Not Applicable |
Web Server Information
Hosted IP Address:
213.227.140.13
Hosted Country:
DE
Location Latitude:
50.1155Location Longitude:
8.68417Search Engine Results For silicofcm.eu
SILICOFCM: Home
The SILICOFCM is a multi-modular, innovative in silico clinical trials solution for the design and functional optimization of whole heart performance and monitoring ...
Project - SILICOFCM
This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 777204. Facebook.
Project Results - SILICOFCM
This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 777204. Facebook.
Objectives - SILICOFCM
This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 777204. Facebook.
About - SILICOFCM
SILICOFCM project will develop in silico computational cloud platform which will ... This project has received funding from the European Union's Horizon 2020 ...
In Silico trials for drug tracing the effects of sarcomeric protein...
6 Dec 2020 ... H2020,SILICOFCM,SC1-PM-16-2017,ISTRAZIVACKO RAZVOJNI ... about COVID-19 and the European Commission's coronavirus response.
Silicofcm Project - Home | Facebook
SILICOFCM project - In Silico trials for drug tracing the effects of sarcomeric ... SILICOFCM.EU. 14th WCCM & ECCOMAS Congress 2020, 11-15 January, 2021 - ...
Silicofcm Project - Home | Facebook
SILICOFCM project - In Silico trials for drug tracing the effects of sarcomeric protein... ... See more of Silicofcm Project on Facebook. Log In. or ... silicofcm.eu.
SILICOFCM Horizon EU Project - Project - BioIRC | LinkedIn
View SILICOFCM Horizon EU Project's profile on LinkedIn, the world's largest professional community. SILICOFCM has 1 job listed on their profile. See the ...
SILICOFCM Project (@silicofcm) | Twitter
This project receives funding from the @EU_H2020 Research & Innovation Programme. Any related tweets reflect only the views of the project owner. silicofcm.eu.
In Silico trials for drug tracing the effects of sarcomeric protein...
The EU Horizon 2020 funded SILICOFCM project (www.silicofcm.eu) will develop a computational platform for in silico clinical trials for familial cardiomyopathies ...
In Silico trials for drug tracing the effects of ... - WBC-RTI.info
9 Mar 2020 ... The SILICOFCM is a multi-modular, innovative in silico clinical trials solution for the design and functional optimization of ... https://silicofcm.eu/.
INSTRUCTIONS TO PREPARE A PAPER FOR THE EUROPEAN ...
cellular aspects) in order to predict patient-specific condition from current through the progression of disease [1]. REFERENCES. [1] www.silicofcm.eu.
Blog – Oactive
Additionally, similar EU funded projects (#SILICOFCM, #CarBon, #PRECISE4Q, #BackUp, InSilc and #EUSTANDS4PM) will present their work in the area of ...
In Silico trials for drug tracing the effects of sarcomeric protein...
- https://www.compbiomed-conference.org/wp-content/uploads/2020/03/Thurs_Nenad_Filpovic_11_20_In-silico-Trials-for-Drug-Tracing-the-Effects-of-Sarcomeric-Protein-Mutations-Leading-to-Familial-Cardiomyopathy-SILICOFCM-Project_smaller.pdf
... has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 777204. SILICOFCM Scope.
Genetic determinants of clinical phenotype in hypertrophic ...
9 Dec 2020 ... ... international multidisciplinary SILICOFCM project (www.silicofcm.eu) ... HCM patients [14], also a fundamental part of the SILICOFCM project.
European Risk & Resilience Institute > News - EU-VRi
During the meeting, participating partners presented their institutions and experience relevant for the SILICOFCM project implementation. Also, the action plan for ...
Hypertrophic cardiomyopathy: disease-causing genes and ...
Methods As a part of the international multidisciplinary SILICOFCM project (www. silicofcm.eu) the present study evaluated the association between underlying ...
SILICOFCM projekat - Operacija srca | Bajpas | Zalistak | Aorta -...
SILICOFCM projekat (In Silico trials for drug tracing the effects of sarcomeric protein ... kao i promotivni film možete naći na sledećem linku: www.silicofcm.eu.
Design of the SILICOFCM study: Effect of sacubitril/valsartan vs ...
3 Mar 2020 ... Maier and Djordje G. Jakovljevic contributed equally to this study. Funding information: European Union's Horizon 2020 Research and Innovation ...
Page Resources Breakdown
Homepage Links Analysis
Website Inpage Analysis
| H1 Headings: | 1 | H2 Headings: | Not Applicable |
| H3 Headings: | Not Applicable | H4 Headings: | Not Applicable |
| H5 Headings: | Not Applicable | H6 Headings: | Not Applicable |
| Total IFRAMEs: | Not Applicable | Total Images: | 6 |
| Google Adsense: | Not Applicable | Google Analytics: | Not Applicable |
Two Phrase Analysis
| Words | Occurrences | Density | Possible Spam |
|---|---|---|---|
| for using | 3 | 1.056 % | No |
| using SILICOFCM | 3 | 1.056 % | No |
| SILICOFCM Platform | 3 | 1.056 % | No |
| Scenarios for | 3 | 1.056 % | No |
| clinical trials | 3 | 1.056 % | No |
| and innovation | 2 | 0.704 % | No |
| innovation programme | 2 | 0.704 % | No |
| research and | 2 | 0.704 % | No |
| 2020 research | 2 | 0.704 % | No |
| Union’s Horizon | 2 | 0.704 % | No |
| Horizon 2020 | 2 | 0.704 % | No |
| programme under | 2 | 0.704 % | No |
| under grant | 2 | 0.704 % | No |
| 777204 Facebook | 2 | 0.704 % | No |
| Facebook Twitter | 2 | 0.704 % | No |
| No 777204 | 2 | 0.704 % | No |
| agreement No | 2 | 0.704 % | No |
| grant agreement | 2 | 0.704 % | No |
| European Union’s | 2 | 0.704 % | No |
| from the | 2 | 0.704 % | No |
Four Phrase Analysis
| Words | Occurrences | Density | Possible Spam |
|---|---|---|---|
| Scenarios for using SILICOFCM | 3 | 1.056 % | No |
| for using SILICOFCM Platform | 3 | 1.056 % | No |
| under grant agreement No | 2 | 0.704 % | No |
| programme under grant agreement | 2 | 0.704 % | No |
| innovation programme under grant | 2 | 0.704 % | No |
| grant agreement No 777204 | 2 | 0.704 % | No |
| agreement No 777204 Facebook | 2 | 0.704 % | No |
| Results Consortium Contact Private | 2 | 0.704 % | No |
| Consortium Contact Private Area | 2 | 0.704 % | No |
| 777204 Facebook Twitter Linkedin | 2 | 0.704 % | No |
| No 777204 Facebook Twitter | 2 | 0.704 % | No |
| and innovation programme under | 2 | 0.704 % | No |
| research and innovation programme | 2 | 0.704 % | No |
| has received funding from | 2 | 0.704 % | No |
| received funding from the | 2 | 0.704 % | No |
| project has received funding | 2 | 0.704 % | No |
| This project has received | 2 | 0.704 % | No |
| in silico clinical trials | 2 | 0.704 % | No |
| funding from the European | 2 | 0.704 % | No |
| from the European Union’s | 2 | 0.704 % | No |
Websites Hosted on Same IP (i.e. 213.227.140.13)
Žiška | Home
Rinfuz digitalnog sadržaja – Social Media content na kilo, digitalna strategija po meri, sajtovi u svim bojama i veličinama. Izvol’te unutra, nije sve stalo u izlog.
3,694,232 
$ 240.00
HTTP Header Analysis
Status-Code: 200
Status: 200 OK
Date: Mon, 22 Mar 2021 18:56:23 GMT
Server: Apache
X-Powered-By: PHP/7.2.34
X-UA-Compatible: IE=edge
Link:
Transfer-Encoding: chunked
Content-Type: text/html; charset=UTF-8
Domain Information
| Domain Registrar: |
EURID
|
|---|
Domain Nameserver Information
| Host | IP Address | Country | |
|---|---|---|---|
| ns319.adriahost.com | |
213.227.140.13 |  Netherlands |
| ns320.adriahost.com | |
213.227.140.51 | Netherlands |
DNS Record Analysis
| Host | Type | TTL | Extra |
|---|---|---|---|
| silicofcm.eu | A | 14385 |
IP: 213.227.140.13 |
| silicofcm.eu | NS | 86400 |
Target: ns319.adriahost.com |
| silicofcm.eu | NS | 86400 |
Target: ns320.adriahost.com |
| silicofcm.eu | SOA | 86400 |
MNAME: ns319.adriahost.com RNAME: adriahostingdcs.gmail.com Serial: 2020050400 Refresh: 3600 Retry: 7200 Expire: 1209600 |
| silicofcm.eu | MX | 14400 |
Target: silicofcm.eu |
| silicofcm.eu | TXT | 14400 |
TXT: v=spf1 ip4:213.227.140.13 +a +mx ~all |
Full WHOIS Lookup
records
% in the EURid WHOIS database are provided for information
purposes
% only. It allows persons to check whether a specific
domain name
% is still available or not and to obtain information
related to
% the registration records of existing domain
names.
%
% EURid cannot, under any circumstances, be held
liable in case the
% stored information would prove to be wrong,
incomplete or not
% accurate in any sense.
%
% By
submitting a query you agree not to use the information made
%
available to:
%
% - allow, enable or otherwise support the
transmission of unsolicited,
% commercial advertising or other
solicitations whether via email or
% otherwise;
% - target
advertising in any possible way;
%
% - to cause nuisance in
any possible way to the registrants by sending
% (whether by
automated, electronic processes capable of enabling
% high volumes
or other possible means) messages to them.
%
% Without
prejudice to the above, it is explicitly forbidden to extract,
%
copy and/or use or re-utilise in any form and by any means
%
(electronically or not) the whole or a quantitatively or
qualitatively
% substantial part of the contents of the WHOIS
database without prior
% and explicit permission by EURid, nor in
any attempt hereof, to apply
% automated, electronic processes to
EURid (or its systems).
%
% You agree that any reproduction
and/or transmission of data for
% commercial purposes will always
be considered as the extraction of a
% substantial part of the
content of the WHOIS database.
%
% By submitting the query you
agree to abide by this policy and accept
% that EURid can take
measures to limit the use of its WHOIS services
% in order to
protect the privacy of its registrants or the integrity
% of the
database.
%
% The EURid WHOIS service on port 43 (textual
whois) never
% discloses any information concerning the
registrant.
% Registrant and on-site contact information can be
obtained through use of the
% webbased WHOIS service available
from the EURid website www.eurid.eu
%
% WHOIS
silicofcm.eu
Domain: silicofcm.eu
Script:
LATIN
Registrant:
NOT DISCLOSED!
Visit www.eurid.eu
for webbased WHOIS.
On-site(s):
NOT DISCLOSED!
Visit
www.eurid.eu for webbased WHOIS.
Registrar:
Name:
Tucows.com Co.
Website:
http:///www.domainhelp.tucows.com/
Name
servers:
ns319.adriahost.com
ns320.adriahost.com
Plea
se visit www.eurid.eu for more info.
Similarly Ranked Websites
Google Chrome - Download the Fast, Secure Browser from Google
Get more done with the new Google Chrome. A more simple, secure, and faster web browser than ever, with Google’s smarts built-in. Download now.
1 $ 16,097,351,400.00
Log into Facebook
Log into Facebook to start sharing and connecting with your friends, family, and people you know.
4 $ 4,024,338,120.00
腾讯网
腾讯网从2003年创立至今，已经成为集新闻信息，区域垂直生活服务、社会化媒体资讯和产品为一体的互联网媒体平台。腾讯网下设新闻、科技、财经、娱乐、体育、汽车、时尚等多个频道，充分满足用户对不同类型资讯的需求。同时专注不同领域内容，打造精品栏目，并顺应技术发展趋势，推出网络直播等创新形式，改变了用户获取资讯的方式和习惯。
5 $ 3,219,470,280.00
Amazon.com. Spend less. Smile more.
- amazon.com
Free shipping on millions of items. Get the best of Shopping and Entertainment with Prime. Enjoy low prices and great deals on the largest selection of everyday essentials and...
8 $ 2,012,168,520.00